Dr. Raymond U. Osarogiagbon
Claim this profileBaptist Memorial Hospital and Cancer Center-Memphis
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
29 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Raymond U. Osarogiagbon is currently running
Observation
for Non-Small Cell Lung Cancer
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
Recruiting1 award N/A10 criteria
Sample Collection
for Cancer
This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Recruiting1 award N/A10 criteria
More about Raymond U. Osarogiagbon
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Raymond U. Osarogiagbon has experience with
- Docetaxel
- Gemcitabine
- Atezolizumab
- Carboplatin
- Cisplatin
- Pemetrexed
Breakdown of trials Raymond U. Osarogiagbon has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Gastrointestinal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raymond U. Osarogiagbon specialize in?
Raymond U. Osarogiagbon focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Raymond U. Osarogiagbon currently recruiting for clinical trials?
Yes, Raymond U. Osarogiagbon is currently recruiting for 4 clinical trials in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Raymond U. Osarogiagbon has studied deeply?
Yes, Raymond U. Osarogiagbon has studied treatments such as Docetaxel, Gemcitabine, Atezolizumab.
What is the best way to schedule an appointment with Raymond U. Osarogiagbon?
Apply for one of the trials that Raymond U. Osarogiagbon is conducting.
What is the office address of Raymond U. Osarogiagbon?
The office of Raymond U. Osarogiagbon is located at: Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee 38120 United States. This is the address for their practice at the Baptist Memorial Hospital and Cancer Center-Memphis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.